Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
admin 15th February 2019 Uncategorised 0While Big Pharma’s price increases these days are in the single digits—and still triggering Twitter outrage—some small companies aren’t shying away from the old strategy of acquiring drugs and jacking up their prices.
More: Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
Source: fierce